JP Morgan Downgrades AlloVir to Underweight
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Anupam Rama has downgraded AlloVir (NASDAQ:ALVR) from Overweight to Underweight, indicating a negative outlook on the company's stock.
December 22, 2023 | 2:29 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
AlloVir has been downgraded by JP Morgan from Overweight to Underweight, suggesting a bearish view on the stock's future performance.
Analyst downgrades typically lead to a negative perception among investors and can result in a short-term decline in the stock price. Given that the downgrade is from Overweight to Underweight, it reflects a significant change in the analyst's view on the stock, which could have a substantial impact on investor sentiment and the stock's market performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100